Valmark Advisers, Inc.
Position in CRL — Charles River Laboratories International, Inc.
CIK 1380443
AKRON, OH
Position in CRL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$680,370
+$162,870 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#269
of 564 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $2,672,414 across 4 Diagnostics & Research names. CRL ranks #2 (25.5% of the industry book) .
All Filings in CRL
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,370 | 3,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $517,500 | 3,000 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $598,440 | 3,000 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $469,380 | 3,000 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $455,190 | 3,000 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $451,560 | 3,000 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $553,800 | 3,000 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $590,910 | 3,000 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $619,740 | 3,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $812,850 | 3,000 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $709,200 | 3,000 | Shares | Sole | 2024-02-02 | |
| No filing history on record for this holder in this stock. | ||||||